Differences in cytomegalovirus plasma viral loads measured in allogeneic hematopoietic stem cell transplant recipients using two commercial real-time PCR assays

Journal of Clinical Virology

Volumn 48, Issue 2, 2010, Pages 142-146

  Gracia Ahufinger, Irene ^a   Tormo, Nuria ^b   Espigado, Ildefonso ^a   Solano, Carlos ^b   Urbano Ispizua, Alvaro ^a   Clari, María A ^b   de la Cruz Vicente, Fatima ^a   Navarro, David ^b,c   Pérez Romero, Pilar ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Allogeneic stem cell transplant; Cytomegalovirus; Real time PCR; Viral load

Indexed keywords

VIRUS DNA;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOMATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA EXTRACTION; GRAFT RECIPIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SPAIN; VIRUS LOAD;

AUTOMATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PLASMA; POLYMERASE CHAIN REACTION; SPAIN; VIRAL LOAD;

EID: 77951621137     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.03.015     Document Type: Article

References (16)

1. Baldanti F., Lilleri D., and Gerna G. Monitoring human cytomegalovirus infection in transplant recipients. J Clin Virol 41 (2008) 237-241
2. Boeckh M., and Ljungman P. How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood 113 (2009) 5711-5719
3. Espy M.J., Uhl J.R., Sloan L.M., et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev 19 (2006) 165-256
4. Pang X.L., Fox J.D., Fenton J.M., Miller G.G., Caliendo A.M., and Preiksaitis J.K. Interlaboratory comparison of cytomegalovirus viral load assays. Am J Transplant 9 (2009) 258-268
5. Wolff D.J., Heaney D.L., Neuwald P.D., Stellrecht K.A., and Press R.D. Multi-site PCR-based CMV viral load assessment-assays demonstrate linearity and precision, but lack numeric standardization: a report of the association for molecular pathology. J Mol Diagn 11 (2009) 87-92
6. Hanson K.E., Reller L.B., Kurtzberg J., Horwitz M., Long G., and Alexander B.D. Comparison of the digene hybrid capture system cytomegalovirus (CMV) DNA (version 2.0), Roche CMV UL54 analyte-specific reagent, and QIAGEN RealArt CMV LightCycler PCR reagent tests using AcroMetrix OptiQuant CMV DNA quantification panels and specimens from allogeneic-stem-cell transplant recipients. J Clin Microbiol 45 (2007) 1972-1973
7. Vincent E., Gu Z., Morgenstern M., Gibson C., Pan J., and Hayden R.T. Detection of cytomegalovirus in whole blood using three different real-time PCR chemistries. J Mol Diagn 11 (2009) 54-59
8. Abbate I., Finnstrom N., Zaniratti S., et al. Evaluation of an automated extraction system in combination with Affigene CMV Trender for CMV DNA quantitative determination: comparison with nested PCR and pp65 antigen test. J Virol Methods 151 (2008) 61-65
9. BenMarzouk-Hidalgo O.J., Cordero E., Martin-Peña A., et al. Prevention of cytomegalovirus disease using pre-emptive treatment after solid organ transplant in patients at high risk for cytomegalovirus infection. Antivir Ther 14 (2009) 641-647
10. Gimeno C., Solano C., Latorre J.C., et al. Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR Kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients. J Clin Microbiol 46 (2008) 3311-3318
11. Yerly S., Perrin L., Van Delden C., et al. Cytomegalovirus quantification in plasma by an automated real-time PCR assay. J Clin Virol 38 (2007) 298-303
12. Harrington S.M., Buller R.S., Storch G.A., et al. The effect of quantification standards used in real-time CMV PCR assays on guidelines for initiation of therapy in allogeneic stem cell transplant patients. Bone Marrow Transplant 39 (2007) 237-238
13. Kalpoe J.S., Kroes A.C., de Jong M.D., et al. Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection. J Clin Microbiol 42 (2004) 1498-1504
14. Limaye A.P., Huang M.L., Leisenring W., Stensland L., Corey L., and Boeckh M. Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients. J Infect Dis 183 (2001) 377-382
15. Ruell J., Barnes C., Mutton K., et al. Active CMV disease does not always correlate with viral load detection. Bone Marrow Transplant 40 (2007) 55-61
16. Verkruyse L.A., Storch G.A., Devine S.M., Dipersio J.F., and Vij R. Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load > or =10000 copies/ml: a safe and effective strategy for allogeneic stem cell transplant patients. Bone Marrow Transplant 37 (2006) 51-56